Daniel Raskas is SVP - Corporate Development of DANAHER CORP . Currently has a direct ownership of 23,595 shares of DHR, which is worth approximately $5.5 Million. The most recent transaction as insider was on Feb 01, 2017, when has been sold 34,168 shares (Common Stock) at a price of $28.55 per share, resulting in proceeds of $975,496. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.6K
0% 3M change
38.37% 12M change
Total Value Held $5.5 Million

Daniel Raskas Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 01 2017
BUY
Exercise of conversion of derivative security
$975,496 $28.55 p/Share
34,168 Added 36.12%
60,429 Common Stock
May 10 2016
BUY
Grant, award, or other acquisition
-
2,635 Added 11.71%
19,859 Common Stock
Apr 22 2016
SELL
Open market or private sale
$2,331,585 $95.95 p/Share
24,300 Reduced 58.52%
17,224 Common Stock
Apr 22 2016
BUY
Exercise of conversion of derivative security
$900,801 $37.07 p/Share
24,300 Added 36.92%
41,524 Common Stock
Feb 23 2016
SELL
Payment of exercise price or tax liability
$164,131 $85.13 p/Share
1,928 Reduced 7.84%
22,663 Common Stock

Also insider at

NVST
Envista Holdings Corp Healthcare
DR

Daniel Raskas

SVP - Corporate Development
Washington, DC

Track Institutional and Insider Activities on DHR

Follow DANAHER CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DHR shares.

Notify only if

Insider Trading

Get notified when an Danaher Corp insider buys or sells DHR shares.

Notify only if

News

Receive news related to DANAHER CORP

Track Activities on DHR